Ocular implant systems
AssigneeGlaukos Corporation
InventorHosheng Tu
Life of this patent
Estimating the term…
Loading patent…
AssigneeGlaukos Corporation
InventorHosheng Tu
Estimating the term…
Intraocular stents and applicators are disclosed for treating glaucoma. The stents are configured to extend between the anterior chamber of the eye and Schlemm's canal for enhancing outflow of aqueous from the anterior chamber so as to reduce intraocular pressure. The stents can have features for anchoring the stent into Schlemm's canal as well as preventing the walls of Schlemm's canal from closing the outlet of the stents. The applicators can be steerable so as to make implantation easier. Additionally, the applicators can be configured to hold a plurality of stents so that multiple stents can be implanted through one incision without removing the applicator from the incision between serial implantations.
A system for implanting device into the eye, comprising:
2-10. (canceled)
12-20. (canceled)
(canceled)
(canceled)
A system for implanting a device into the eye, comprising:
25-32. (canceled)
(canceled)
(canceled)
37-41. (canceled)
43-92. (canceled)
A system, comprising:
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
109-128. (canceled)
A system for implanting a device into the eye, comprising:
130-135. (canceled)
(canceled)
140-144. (canceled)
146-185. (canceled)
An ocular implant system, comprising:
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.